Enterprise Value to EBITDA Multiple ratio Analysis of Verona Pharma PLC - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY EV to EBITDA
Period Ending - Dec-23
Very Poor EV to EBITDA
-158124.94
Period Ending - Dec-22
Very Poor EV to EBITDA
-0.0073
Growth
-2160615912.17 %
Trailing Twelve Months EV to EBITDA
Period Ending - Dec-23
Very Poor EV to EBITDA
-12.02
EV to EBITDA Analysis of Verona Pharma PLC
| EV to EBITDA Ratio of VRNA drastically fell by -2160615912.17 % this year. |
| EV to EBITDA Ratio with value of -0.0073 was highest in Year Dec-22 in last Five Years. |
| EV to EBITDA Ratio with value of -158124.94 was lowest in Year Dec-23 in last Five Years. |
| Latest EV to EBITDA Ratio with value of -158124.94 is lower than Average EV to EBITDA of -31628.25 in last five years. |
Other EV to EBITDA Related Info of VRNA that may interest you.
Verona Pharma PLC Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| VRNA | 12.07 | 11.48 | 5.14 % | Biotechnology |
Defination of Enterprise Value to EBITDA Multiple
Enterprise Value-to-EBITDA Ratio is used to compare a company's Enterprise Value to its EBITDA (Earnings before Interest, Taxes, Depreciation, and Amortization). It is useful to determine the value of a company, whether it is undervalued or overvalued. more ..
EV to EBITDA Related Ratios
| EBITDAMargin | EVToRevenue | PriceToEarningRatio |
Tsr Value Index
| Very Low Value Stock | |
FY - Historical Enterprise Value to EBITDA Multiple of Verona Pharma PLC
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
|---|---|---|---|---|---|---|---|
| EV to EBITDA | -158124.94 | -0.0073 | -10.46 | -3.33 | -2.54 | -4.38 | 14650.76 |
| Change | -2160615912.17 % | 99.93 % | -214.15 % | -30.98 % | 41.94 % | -100.03 % | 4350.01 % |
FY Chart of Enterprise Value to EBITDA Multiple of Verona Pharma PLC
Note : All Data Generated at the End of Trading Hours (EOD Data)